IL117797A0 - Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases - Google Patents

Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

Info

Publication number
IL117797A0
IL117797A0 IL11779796A IL11779796A IL117797A0 IL 117797 A0 IL117797 A0 IL 117797A0 IL 11779796 A IL11779796 A IL 11779796A IL 11779796 A IL11779796 A IL 11779796A IL 117797 A0 IL117797 A0 IL 117797A0
Authority
IL
Israel
Prior art keywords
inhibition
treatment
compounds useful
proliferative diseases
protein function
Prior art date
Application number
IL11779796A
Original Assignee
Pharmacopeia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacopeia Inc filed Critical Pharmacopeia Inc
Publication of IL117797A0 publication Critical patent/IL117797A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11779796A 1995-04-07 1996-04-02 Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases IL117797A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41898095A 1995-04-07 1995-04-07

Publications (1)

Publication Number Publication Date
IL117797A0 true IL117797A0 (en) 1996-08-04

Family

ID=23660310

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11779796A IL117797A0 (en) 1995-04-07 1996-04-02 Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

Country Status (3)

Country Link
AU (1) AU5432796A (en)
IL (1) IL117797A0 (en)
WO (1) WO1996031505A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117641A (en) 1996-04-11 2000-09-12 Mitotix, Inc. Assays and reagents for identifying anti-fungal agents and uses related thereto
US6727082B1 (en) 1996-04-11 2004-04-27 Gpc Biotech Inc. Assays and reagents for identifying anti-fungal agents, and uses related thereto
JP2001513622A (en) 1996-04-11 2001-09-04 マイトティックス インコーポレーテッド Assays and reagents for the identification of antimicrobial agents and their related uses
WO1998057964A1 (en) * 1997-06-17 1998-12-23 Schering Corporation Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
CN1267290A (en) * 1997-06-17 2000-09-20 先灵公司 Tricyclic sulfonamide inhibitors of farnesyl-protein transferase
US5925639A (en) * 1997-06-17 1999-07-20 Schering Corporation Keto amide derivatives useful as farnesyl protein transferase inhibitors
US6225322B1 (en) 1997-06-17 2001-05-01 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6426352B1 (en) 1997-06-17 2002-07-30 Schering Corporation Sulfonamide inhibitors of farnesyl-protein transferase
DE69825589T2 (en) * 1997-06-17 2005-09-08 Schering Corp. BENZPYRIDO CYCLOHEPTAN DERIVATIVES WITH FARNESYL PROTEIN TRANSFERASE INHIBIVING EFFECT
US6242493B1 (en) 1998-03-13 2001-06-05 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO1999047497A2 (en) * 1998-03-13 1999-09-23 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
US6372747B1 (en) 1998-12-18 2002-04-16 Schering Corporation Farnesyl protein transferase inhibitors
US7417026B2 (en) 2003-08-13 2008-08-26 Children's Hospital Medical Center Mobilization of hematopoietic cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2098198A1 (en) * 1990-12-18 1992-06-18 Ann Christie King Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
EP0703905A1 (en) * 1993-06-18 1996-04-03 Merck & Co. Inc. Inhibitors of farnesyl-protein transferase
JP2875393B2 (en) * 1993-10-15 1999-03-31 シェーリング コーポレイション Tricyclic carbamate compounds useful for inhibiting G-protein function and treating proliferative disorders
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Pharmaceutical compositions for inhibition of g-protein function and for treatment of proliferative diseases containing tricyclic compounds some such compounds and process for preparing part of them
HUT76057A (en) * 1993-10-15 1997-06-30 Schering Corp Tricyclic sulfonamide compounds, pharmaceutical compositions containing them, which are useful for inhibition of g-protein function and for treatment of proliferative diseases and process for producing them

Also Published As

Publication number Publication date
WO1996031505A1 (en) 1996-10-10
AU5432796A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
IL117798A0 (en) Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117603A0 (en) Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
HUP9903705A3 (en) Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
AU5189196A (en) Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117604A0 (en) Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117602A0 (en) Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
AU2912997A (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
AU6594796A (en) Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases
IL119894A0 (en) Thiazolidine derivatives for treatment of osteoporosis
IL117797A0 (en) Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
AU5901896A (en) Use of aryl-substituted cyclobutylalkylamines for treating obesity
AU8058498A (en) Carboxy piperidylacetamide tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors)
IL115320A0 (en) Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
EP0859761A4 (en) 4-azasteroids for treatment of hyperandrogenic conditions
HK1002865A1 (en) Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
GB9602162D0 (en) Treatment of waste
ZA9610735B (en) Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
AU8253498A (en) Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
HUP9801338A3 (en) Use of tricyclic carbamate derivatives for inhibition of g-protein function and for treatment of proliferative diseases
GB9508792D0 (en) Surface treatment of materials
SI0828486T1 (en) Use of pyrrolidine derivatives for treating alcoholism
GB9517498D0 (en) Treatment of waste materials
GB9503795D0 (en) Use of organic compounds
HUT76735A (en) Method for treatment of sludges
GB9517143D0 (en) Treatment of soil